Department of Dermatology, Venereology and Allergology, University of Würzburg, Josef-Schneider-Strasse 2, D-97080 Würzburg, Germany.
Eur J Dermatol. 2010 Mar-Apr;20(2):217-9. doi: 10.1684/ejd.2010.0876. Epub 2010 Feb 15.
A 51-year-old man suffered from an acute eczematous rash confined to the air- and light-exposed areas of the skin. As a construction worker he was exposed to common occupational allergens such as epoxy resins, but there was also remarkable holiday-associated sun exposure. He did not use any sunscreen agents. Several weeks before the onset of skin eruptions, conservative treatment of Peyronie's disease with oral PotabaTM (potassium paraaminobenzoate) had been started. Airborne contact dermatitis to volatile allergens was ruled out, while photopatchtesting revealed photoallergy to paraaminobenzoic acid (PABA). In sunscreens, PABA has mostly been abandoned due to its known topical photosensitization properties, but it has not yet been recognized as a systemic photosensitizer.
一位 51 岁男性,患急性湿疹样皮疹,局限于暴露于空气和光线的皮肤区域。他是一名建筑工人,接触常见的职业性过敏原,如环氧树脂,但也有明显的与假期相关的阳光暴露。他没有使用任何防晒霜。在皮肤疹出现前几周,开始口服 PotabaTM(对氨基苯甲酸钾)治疗 Peyronie 病。排除了空气传播接触性皮炎的挥发性过敏原,而光斑贴试验显示对氨基苯甲酸(PABA)的光过敏。在防晒霜中,PABA 由于其已知的局部光敏性而大多被摒弃,但尚未被认为是全身性光敏剂。